Company intelligence
Neuromod
The standard-bearer for scientifically-proven tinnitus treatment.
About Neuromod
Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control of their own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle. Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
Verified activity
Signals from Neuromod
3 published signals
Presence & Recognition
Neuromod is attending the XXIII World Congress of Otorhinolaryngology, IFOS Istanbul 2026, from September 9 to 13, bringing together ENT and hearing healthcare professionals.
Reported by Neuromod
Presence & Recognition
Neuromod published an in-depth feature article in The Age by Angus Holland interviewing Melbourne-based tinnitus specialist Mini Gupta and Neuromod CEO Dr. Ross O'Neill.
Reported by Neuromod
Products & Services
Neuromod launched Lenire, an evidence-based treatment option for people living with tinnitus in Australia.
Reported by Diarmuid Flavin